Insider Trading & Ownership of Ansbert Gadicke

Location: Boston, MA
Summary: The estimated net worth of Ansbert Gadicke is at least $207,065,627 dollars as of 14 Jan 2026. Ansbert Gadicke is the Director of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $102.72M. Ansbert Gadicke is the 10%+ Owner of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. stock worth about $51.26M. Ansbert Gadicke is the Former 10% Owner of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. stock worth about $27.83M. Ansbert Gadicke is the Director, 10%+ Owner of Allovir, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $11.21M. Ansbert Gadicke is the 10%+ Owner of Repare Therapeutics Inc. and owns shares of Repare Therapeutics Inc. (RPTX) stock worth about $9.42M. Ansbert Gadicke is the Former 10% Owner of Werewolf Therapeutics, Inc. and owns shares of Werewolf Therapeutics, Inc. (HOWL) stock worth about $4.64M.
Signature: /s/ Ansbert Gadicke
All Insider Reports: All Insider Reports

Notify me when Ansbert Gadicke files a new Insider Trading report.

Ownership of Ansbert Gadicke

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
CGEM	Cullinan Oncology, Inc.	Director	$102,717,212			22 Jun 2022
HARP	Harpoon Therapeutics, Inc.	10%+ Owner	$51,257,570			28 May 2021
ITOS	iTeos Therapeutics, Inc.	Former 10% Owner	$27,829,543	-$8,317,364	-23%	13 May 2025
KLRS	Allovir, Inc.	Director, 10%+ Owner	$11,205,689			28 Jul 2022
RPTX	Repare Therapeutics Inc.	10%+ Owner	$9,415,026			09 Jul 2021
HOWL	Werewolf Therapeutics, Inc.	Former 10% Owner	$4,640,587	-$2,227,963	-32%	02 Dec 2025
AKTS	Aktis Oncology, Inc.	10%+ Owner				12 Jan 2026
TCRR	TCR2 THERAPEUTICS INC.	Director, 10%+ Owner				01 Jun 2023

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.